Showing 1 - 13 results of 13 for search 'Makoto Maemondo', query time: 0.05s
Refine Results
-
1
Role of genetic variations of chitinase 3-like 1 in bronchial asthmatic patients by Kazuyuki Abe, Yutaka Nakamura, Kohei Yamauchi, Makoto Maemondo
Published 2018-04-01
Article -
2
-
3
A Case of Mediastinal Tuberculous Lymphadenitis in a Chronic Dialysis Patient Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) by Hiromi Nagashima, Kazuyuki Abe, Yukihiro Owada, Kazuhiro Yakuwa, Hiroshi Katagiri, Shinji Chiba, Ami Matsumoto, Masachika Akiyama, Yu Utsumi, Makoto Maemondo
Published 2023-03-01
Article -
4
Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M Mutation by Kana Watanabe, Ryota Saito, Eisaku Miyauchi, Hiromi Nagashima, Atsushi Nakamura, Shunichi Sugawara, Nobuyuki Tanaka, Hiroshi Terasaki, Tatsuro Fukuhara, Makoto Maemondo
Published 2023-08-01
Article -
5
The Frequency of DNA Mismatch Repair Deficiency Is Very Low in Surgically Resected Lung Carcinoma by Naoki Yanagawa, Noriyuki Yamada, Ryo Sugimoto, Mitsumasa Osakabe, Noriyuki Uesugi, Satoshi Shiono, Makoto Endoh, Shin-ya Ogata, Hajime Saito, Makoto Maemondo, Tamotsu Sugai
Published 2021-10-01
Article -
6
Prognostic and predictive value of CD163 expression and the CD163/CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cel... by Naoki Yanagawa, Shunsuke Shikanai, Mayu Sugai, Yoshihiko Koike, Yoshinari Asai, Takayuki Tanji, Ryo Sugimoto, Mitsumasa Osakabe, Noriyuki Uesugi, Hajime Saito, Makoto Maemondo, Tamotsu Sugai
Published 2023-07-01
Article -
7
Relationship between Trace Element in Tumor and Prognosis in Lung Cancer Patients by Hirotaka Saikawa, Hiromi Nagashima, Katsuya Cho, Ryosuke Chiba, Koichiro Sera, Wataru Shigeeda, Makoto Tomoyasu, Hiroyuki Deguchi, Fumiaki Takahashi, Hajime Saito, Tamotsu Sugai, Makoto Maemondo
Published 2021-02-01
Article -
8
A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety by Tatsuro Fukuhara, Kazuhiro Imai, Taku Nakagawa, Ryotaro Igusa, Hayato Yokota, Kana Watanabe, Aya Suzuki, Mami Morita, Ren Onodera, Akira Inoue, Masatomo Miura, Yoshihiro Minamiya, Makoto Maemondo
Published 2023-09-01
Article -
9
Gastrointestinal involvement in patients with vasculitis: IgA vasculitis and eosinophilic granulomatosis with polyangiitis by Keisuke Kawasaki, Shotaro Nakamura, Motohiro Esaki, Koichi Kurahara, Makoto Eizuka, Yasuharu Okamoto, Takashi Hirata, Minako Hirahashi, Yumi Oshiro, Shunichi Yanai, Kunihiko Sato, Yosuke Toya, Makoto Maemondo, Yasuo Terayama, Tamotsu Sugai, Takayuki Matsumoto
Published 2019-10-01
Article -
10
Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistanceResearch in context by Koutaroh Okada, Mitsugu Araki, Takuya Sakashita, Biao Ma, Ryo Kanada, Noriko Yanagitani, Atsushi Horiike, Sumie Koike, Tomoko Oh-hara, Kana Watanabe, Keiichi Tamai, Makoto Maemondo, Makoto Nishio, Takeshi Ishikawa, Yasushi Okuno, Naoya Fujita, Ryohei Katayama
Published 2019-03-01
Article -
11
Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first‐line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG... by Hisashi Tanaka, Yukihiro Hasegawa, Yuka Fujita, Atsushi Nakamura, Eiki Kikuchi, Yasutaka Kawai, Toshiyuki Harada, Naomi Watanabe, Hiroshi Yokouchi, Kazuhiro Usui, Ryota Saito, Hiroshi Watanabe, Tomomi Masuda, Tatsuro Fukuhara, Keita Kudo, Ryoichi Honda, Satoshi Oizimi, Makoto Maemondo, Akira Inoue, Naoto Morikawa
Published 2021-07-01
Article -
12
Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and... by Hidehito Horinouchi, Makoto Nishio, Toyoaki Hida, Kazuhiko Nakagawa, Hiroshi Sakai, Naoyuki Nogami, Shinji Atagi, Toshiaki Takahashi, Hideo Saka, Mitsuhiro Takenoyama, Nobuyuki Katakami, Hiroshi Tanaka, Koji Takeda, Miyako Satouchi, Hiroshi Isobe, Makoto Maemondo, Koichi Goto, Tomonori Hirashima, Koichi Minato, Naoki Sumiyoshi, Tomohide Tamura
Published 2019-09-01
Article -
13
Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study by Tatsuro Fukuhara, Haruhiro Saito, Naoki Furuya, Kana Watanabe, Shunichi Sugawara, Shunichiro Iwasawa, Yoshio Tsunezuka, Ou Yamaguchi, Prof Morihito Okada, Kozo Yoshimori, Ichiro Nakachi, Prof Akihiko Gemma, Koichi Azuma, Futoshi Kurimoto, Yukari Tsubata, Yuka Fujita, Hiromi Nagashima, Gyo Asai, Satoshi Watanabe, Masaki Miyazaki, Prof Koichi Hagiwara, Prof Toshihiro Nukiwa, Prof Satoshi Morita, Prof Kunihiko Kobayashi, Prof Makoto Maemondo
Published 2020-07-01
Article